News & Events
July 26, 2018
First-ever biomarker qualified for Parkinson’s is a vital step toward improved clinical trialsFOR IMMEDIATE RELEASE Contact: Kissy Black 615.298.1144 email@example.com Tucson, AZ — July 26, 2018 – The Critical Path Institute’s (C-Path) Critical Path for Parkinson’s Consortium (CPP), in partnership with Parkinson’s UK, announces that the European Medicines Agency (EMA) has issued a positive qualification opinion on an imaging test (biomarker) as a tool to enrich......
May 7, 2018
C-Path Receives COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)TUCSON, Ariz. – May 7, 2018 — Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium announces its second clinical outcome assessment (COA) qualification from the US Food and Drug Administration (FDA). The qualification of the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) for exploratory use represents another major milestone for the PRO Consortium and,......
April 16, 2018
Helmsley Charitable Trust Awards Critical Path Institute a Grant to Focus on Crohn’s Disease BiomarkersTucson, AZ, and New York, NY – April 16, 2018 — The Leona M. and Harry B. Helmsley Charitable Trust has awarded Critical Path Institute (C-Path) a grant to support a Crohn’s disease biomarker pre-consortium. The pre-consortium will identify unmet needs for the use of biomarkers in developing new treatments for people with Crohn’s disease. Currently,......
February 5, 2018
Critical Path to TB Drug Regimens (CPTR) 2018 Annual Workshop, postponedCritical Path Institute and Bill & Melinda Gates Foundation have decided to postpone the Critical Path to TB Drug Regimens Workshop (CPTR) 2018 Annual workshop originally scheduled for April 23-25, 2018. This workshop will be rescheduled later in 2018 to better align with deliverables from our programmatic efforts and alleviate some of the logistical challenges......
May 9, 2017
Two Arizona leaders in scientific collaboration partner to advance global TB researchMay 1, 2017 Two Arizona leaders in scientific collaboration partner to advance global TB research TUCSON and FLAGSTAFF, May 1, 2017 –Two Arizona leaders in worldwide scientific collaboration and infectious disease research have joined forces to improve global tuberculosis (TB) treatment regimens by studying drug resistance. The Bill & Melinda Gates Foundation has......